Market revenue in 2022 | USD 32.2 million |
Market revenue in 2030 | USD 52.7 million |
Growth rate | 6.4% (CAGR from 2022 to 2030) |
Largest segment | Extracorporeal co2 machines |
Fastest growing segment | Other Products |
Historical data covered | 2017 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Extracorporeal CO2 machines, Disposables, Other Products |
Key market players worldwide | Medtronic PLC, Getinge AB ADR, Fresenius Medical Care AG, LivaNova PLC, Aferetica, Estor |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to extracorporeal co2 removal devices market will help companies and investors design strategic landscapes.
Extracorporeal co2 machines was the largest segment with a revenue share of 50.93% in 2022. Horizon Databook has segmented the North America extracorporeal co2 removal devices market based on extracorporeal co2 machines, disposables, other products covering the revenue growth of each sub-segment from 2017 to 2030.
North America accounted for the largest revenue share as it has a highly regulated and developed healthcare infrastructure. Increase in collective efforts by key players to improve product portfolio and ensure high-quality standards are expected to boost the demand for extracorporeal CO2 removal devices across this region. For instance, in February 2018, Stryker entered into definitive agreement to acquire Entellus Medical, Inc.
Medtronic, Alung Technologies, Xenios AG, ESTOR S.P.A, and others are some of the key players in the North America extracorporeal CO2 removal devices market focusing on high R&D investment to deliver technically advanced product portfolio in the market. In addition, increasing prevalence of acute respiratory failure in the U.S. and Canada is further expected to fuel market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America extracorporeal co2 removal devices market, including forecasts for subscribers. This continent databook contains high-level insights into North America extracorporeal co2 removal devices market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account